All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India.
Institute of Life Sciences, Bhubaneswar, 751023, Odisha, India.
Indian J Med Microbiol. 2024 May-Jun;49:100601. doi: 10.1016/j.ijmmb.2024.100601. Epub 2024 May 15.
Acute Hemorrhagic conjunctivitis (AHC) is associated with CVA24v. Recently there was a severe outbreak of conjunctivitis in months of July and August 2023 in India. This study emphasizes the identification of the distinct mutations in the CVA24v strains, which were isolated during the AHC outbreak and could have potentially played a role in the high transmission of AHC in India during the 2023 outbreak.
A total of 71 conjunctivitis patients aged 1-75 years comprising 47 males and 24 females who attended Ophthalmology department of a tertiary care hospital of easternIndia were studied.RNA was extracted from all conjunctival swab samples and converted into cDNA. Subsequently, the viral 5' UTR was amplified and the PCR positive samples were subjected to sequencing. The newly isolated viral 5' UTR sequences were aligned with other worldwide sequences using the Clustal W tool to conduct mutational analysis. A phylogenetic tree was built using the MEGA software for viral genotype identification.
All of the current outbreak strains belonged to genotype IV of CVA24v. The present outbreak strains formed a distinct clade in the phylogenetic tree and were different from previously reported Indian strains. Two persistent mutations, specifically in domain IV (T213C) and domain V (C475T), were exclusively detected within the internal ribosome entry site (IRES) of the 5' UTR of the current strains causing the outbreak. These two alterations have previously been shown to impact the virulence of another enterovirus (CV B3), but they have not been described in CVA24v until now.
Finding of the present study highlights the possibility and the significance of the aforementioned two mutations in enhancing the transmissibility of the newer CVA24v strains. Hence, these two distinct mutations should be investigated further for developing antiviral therapies to combat future AHC outbreaks associated with CVA24v.
急性出血性结膜炎(AHC)与 CVA24v 相关。最近,2023 年 7 月和 8 月印度爆发了严重的结膜炎疫情。本研究强调了在 AHC 爆发期间分离到的 CVA24v 菌株中独特突变的鉴定,这些突变可能在 2023 年印度 AHC 爆发期间发挥了高传播作用。
共研究了 71 例年龄在 1-75 岁之间的结膜炎患者,其中男性 47 例,女性 24 例,他们均来自印度东部一家三级保健医院的眼科。从所有结膜拭子样本中提取 RNA,并将其转化为 cDNA。随后,扩增病毒 5'UTR,并对 PCR 阳性样本进行测序。使用 Clustal W 工具将新分离的病毒 5'UTR 序列与其他全球序列进行比对,以进行突变分析。使用 MEGA 软件构建病毒基因型鉴定的系统发育树。
所有当前暴发株均属于 CVA24v 的基因型 IV。本暴发株在系统发育树上形成了一个独特的分支,与之前报道的印度株不同。两个持续存在的突变,特别是在 IV 结构域(T213C)和 V 结构域(C475T),仅在当前流行株 5'UTR 的内部核糖体进入位点(IRES)中检测到。这两个改变之前已被证明会影响另一种肠道病毒(CV B3)的毒力,但在 CVA24v 中尚未有描述。
本研究结果强调了上述两个突变增强新型 CVA24v 株传播能力的可能性和重要性。因此,应该进一步研究这两个独特的突变,以开发针对与 CVA24v 相关的未来 AHC 暴发的抗病毒疗法。